Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2022 ∙ Cheung, K. S. Mok, C. H. Mao, X. Zhang, R. Hung, I. F. Seto, W. K. Yuen, M. F.

COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Administration
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Knudsen, B. Prasad, V.

COVID-19 vaccine induced myocarditis in young males: A systematic review

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Sun, H. Bu, F. Li, L. Zhang, X. Yan, J. Huang, T.

COVID-19 vaccine response and safety in patients with cancer: An overview of systematic reviews

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Galanis, P. Vraka, I. Katsiroumpa, A. Siskou, O. Konstantakopoulou, O. Katsoulas, T. Mariolis-Sapsakos, T. Kaitelidou, D.

COVID-19 Vaccine Uptake among Healthcare Workers: A Systematic Review and Meta-Analysis

  • All age groups
  • Healthcare workers
  • COVID-19
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Elnahry, A. G. Al-Nawaflh, M. Y. Gamal Eldin, A. A. Solyman, O. Sallam, A. B. Phillips, P. H. Elhusseiny, A. M.

COVID-19 Vaccine-Associated Optic Neuropathy: A Systematic Review of 45 Patients

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Khan, Z. Pabani, U. K. Gul, A. Muhammad, S. A. Yousif, Y. Abumedian, M. Elmahdi, O. Gupta, A.

COVID-19 Vaccine-Induced Myocarditis: A Systemic Review and Literature Search

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Allahyari, F. Molaee, H. Hosseini Nejad, J.

Covid-19 vaccines and neurological complications: a systematic review

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Yazdani, A. Mirmosayyeb, O. Ghaffary, E. M. Hashemi, M. S. Ghajarzadeh, M.

COVID-19 vaccines and patients with multiple sclerosis: willingness, unwillingness and hesitancy: a systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Novillo, B. Martínez-Varea, A.

COVID-19 Vaccines during Pregnancy and Breastfeeding: A Systematic Review

  • All age groups
  • Pregnant women
  • Parents/caregivers
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Flacco, M. E. Acuti Martellucci, C. Baccolini, V. De Vito, C. Renzi, E. Villari, P. Manzoli, L.

COVID-19 vaccines reduce the risk of SARS-CoV-2 reinfection and hospitalization: Meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...